Puma Biotechnology, Inc. (PBYI) revenue

Revenue · fiscal 2025
$228.37M

Puma Biotechnology, Inc. (PBYI) reported revenue of $228.37M in fiscal 2025 (the year ended December 31, 2025). That is 0.9% lower than the $230.47M of fiscal 2024. Figures as of 18 Nov 2026, 11:14 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$228.37M
Change on fiscal 2024
−0.9%
Growth, 5 years
+0.3% a year
Highest on record
$272.26Mfiscal 2019
Lowest on record
$27.69Mfiscal 2017
Fiscal years on record
92017–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Puma Biotechnology, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 0.3% a year. Across the 9 fiscal years on record (2017–2025), the highest was $272.26M in fiscal 2019 and the lowest $27.69M in fiscal 2017.

History · 9 fiscal years

Revenue by fiscal year

Puma Biotechnology, Inc. revenue, year by year

Puma Biotechnology, Inc. (PBYI) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$228.37M 0.9% down
2024$230.47M 2.2% down
2023$235.64M 3.3% up
2022$228.03M 9.9% down
2021$253.16M 12.5% up
2020$225.11M 17.3% down
2019$272.26M 8.5% up
2018$250.99M 806.6% up
2017$27.69M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on PBYI

Puma Biotechnology, Inc., figure by figure

Puma Biotechnology, Inc. (PBYI) overview: price, valuation and scorecard

Puma Biotechnology, Inc. revenue: questions and answers

What is Puma Biotechnology, Inc.'s revenue?

Puma Biotechnology, Inc. (PBYI) reported revenue of $228.37M in fiscal 2025 (the year ended December 31, 2025). That is 0.9% lower than the $230.47M of fiscal 2024.

What is the growth rate of Puma Biotechnology, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 0.3% a year.

What are the highest and lowest revenue figures on record for Puma Biotechnology, Inc.?

Across the 9 fiscal years on record (2017–2025), the highest was $272.26M in fiscal 2019 and the lowest $27.69M in fiscal 2017.

How is Puma Biotechnology, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement. For Puma Biotechnology, Inc. it is on record here for 9 fiscal years, 2017 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Puma Biotechnology, Inc. (PBYI) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/PBYI/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.